Steve Xanthoudakis

Mark Henderson
September 19, 2017

Steve Xanthoudakis has been appointed chief business development officer for CQDM, a non-profit biopharmaceutical research consortium and an industrial research cluster with a mission to fund projects which accelerate the development of drugs. Xanthoudakis has more than 25 years of biopharma experience including senior research scientist and director of global business development & licensing for Merck Research Laboratories — positions he held since 1996. At CQDM, he will be responsible for evolving its business development strategy with an emphasis on consolidating global pharma support for technology sourced across the continuum of both Canadian academic and biotech research.  Xanthoudakis holds a PhD in microbiology and immunology from McGill Univ and has received post-doctoral training at the Roche Institute of Molecular Biology in New Jersey.


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.